Related Experiment Videos
Transforming growth factor beta 1-specific binding proteins on human vascular endothelial cells
Experimental Cell Research
|July 1, 1992
Summary
Transforming growth factor beta (TGF-β) differentially affects human umbilical vein endothelial cell (HUVEC) growth. A gelatin coating confers resistance to TGF-β inhibition, suggesting extracellular matrix involvement in growth regulation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor beta (TGF-β) isoforms differentially regulate human umbilical vein endothelial cell (HUVEC) growth.
- HUVEC exhibit resistance to TGF-β growth inhibition when cultured on gelatin-coated substrata.
Purpose of the Study:
- To investigate the mechanisms underlying TGF-β's differential regulation of HUVEC growth.
- To identify and characterize TGF-β binding proteins on HUVEC.
Main Methods:
- HUVEC proliferation assays under varying culture conditions.
- 125I-TGF-β1 binding assays to determine binding site affinity and density.
- Affinity cross-linking studies to identify TGF-β binding proteins.
Main Results:
- HUVEC possess high-affinity TGF-β1 binding sites (Kd = 4.4 pM, 8500 sites/cell).
- HUVEC express 180 and 80 kDa TGF-β1 binding proteins, distinct from the type III TGF-β receptor.
- Gelatin coating does not alter TGF-β1 binding site expression.
Conclusions:
- A novel TGF-β1-specific receptor/binding protein may be involved in HUVEC growth regulation.
- TGF-β1-induced growth inhibition in HUVEC is likely mediated by extracellular matrix interactions, not altered receptor expression.